Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
SLAS Discovery : Advancing Life Sciences R & D|March 28, 2017
A Label-Free Continuous Fluorescence-Based Assay for Monitoring Ornithine Decarboxylase Activity with a Synthetic Putrescine ReceptorMohamed Nilam, Philip Gribbon, Jeanette Reinshagen, et al.Clinical Oral Implants Research|May 16, 2002
Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogsHenning Schliephake, Dieter Scharnweber, Michael Dard, et al.Tissue Engineering. Part A|July 10, 2008
Additive effect of RGD coating to functionalized titanium surfaces on human osteoprogenitor cell adhesion and spreadingDelphine Le Guillou-Buffello, Reine Bareille, Marcel Gindre, et al.Studies in Health Technology and Informatics|May 17, 2025
Towards Semantic Interoperability Health Standardization Recommendation ToolAmelie Gyrard, Somayeh Abedian, Philip Gribbon, et al.Journal of Biomolecular Screening|April 23, 2013
Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approachesHannieh Sotoud, Philip Gribbon, Bernhard Ellinger, et al.Journal of Chemical Information and Modeling|February 23, 2025
Predicting Antimicrobial Class Specificity of Small Molecules Using Machine LearningYojana Gadiya, Olga Genilloud, Ursula Bilitewski, et al.Bioinformatics (Oxford, England)|June 28, 2025
KGG: a fully automated workflow for creating disease-specific knowledge graphsReagon Karki, Yojana Gadiya, Andrea Zaliani, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|March 29, 2025
Calcium Sulfate Bone Substitutes in Clinical Use: History, Material Properties, Application, and Outlook for the FutureJosina Straub, Andreas Sewing, Nike Walter, et al.Frontiers in Pharmacology|October 17, 2017
The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 ReceptorReggie Bosma, Gesa Witt, Lea A I Vaas, et al.Journal of Medical Virology|April 2, 2025
Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2Philipp Reus, Emma Torbica, Tamara Rothenburger, et al.Pageof 11